Small Stocks, Big Money™

Jupiter Neurosciences (Nasdaq: JUNS) partnered with Zina Biopharmaceuticals to support its Phase 2a clinical trial for JOTROL™, a patented resveratrol-based therapy targeting Parkinson’s disease. Zina will oversee trial execution, regulatory strategy, and site selection, accelerating Jupiter’s development timeline. JOTROL™’s advanced formulation significantly boosts bioavailability while reducing side effects, addressing a major limitation of traditional resveratrol. With the global Parkinson’s market projected to surpass $14 billion by 2030, this collaboration positions Jupiter for future pivotal studies in neuroinflammatory and CNS disorders.

Trinity Biotech (Nasdaq: TRIB) announced exceptional results from its latest pre-pivotal trial for its next-generation continuous glucose monitoring (CGM) system. Designed to be affordable, accurate, and eco-friendly, the modular device features a reusable applicator and rechargeable transmitter, eliminating costly disposable components—a game-changer in a CGM market projected to exceed $20 billion by 2029. Trial results showed a 25-30% accuracy improvement over previous models, aligning with industry standards for low-glucose precision. With European and U.S. regulatory filings on the horizon, Trinity is on track to disrupt a market currently dominated by high-cost solutions.

ConnectM Technology Solutions (Nasdaq: CNTM) acquired MHz Invensys, a leader in wireless communication technologies, in an all-stock transaction to enhance its Advanced Metering Infrastructure (AMI) solutions. This strategic move strengthens ConnectM’s position in the $47 billion AMI market, with expectations to generate an additional $15 million in revenue from the sector by 2027. MHz Invensys’ RF mesh-based technology enables seamless, bidirectional smart meter communication, improving efficiency across electricity, gas, and water metering. With this acquisition, ConnectM is poised to expand into high-growth markets such as solar grid monitoring, IoT, and industrial automation.

Fathom Holdings (Nasdaq: FTHM) has teamed up with Locafy Limited (Nasdaq: LCFY) to provide its 14,500+ real estate agents with cutting-edge SEO technology, enhancing their visibility in local search results. By leveraging Locafy’s proprietary entity-based SEO solutions, Fathom agents can achieve first-page search rankings, making it easier for buyers and sellers to connect with real estate professionals in their communities. This scalable partnership strengthens Fathom’s tech-driven approach to real estate, empowering agents with powerful digital marketing tools to drive more transactions and grow their business.